As boost­er sea­son awaits, US re-ups sup­ply of Pfiz­er Covid-19 vac­cine with new $3.2B deal

The US gov­ern­ment said late Wednes­day that it will pay Pfiz­er and its part­ner BioN­Tech $3.2 bil­lion up­on re­ceipt of the first 105 mil­lion Covid-19 vac­cine dos­es, po­ten­tial­ly the new Omi­cron-adapt­ed boost­ers pend­ing EUA.

Un­der this agree­ment, the US gov­ern­ment al­so has the op­tion to pur­chase up to 195 mil­lion ad­di­tion­al dos­es, bring­ing the to­tal num­ber of po­ten­tial new dos­es to 300 mil­lion. The US has now spent al­most $15 bil­lion on Pfiz­er’s Covid-19 vac­cine.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER